Development of hematopoietic syndrome mice model for localized radiation exposure

Abstract Current models to study the hematopoietic syndrome largely rely on the uniform whole-body exposures. However, in the radio-nuclear accidents or terrorist events, exposure can be non-uniform. The data available on the non-uniform exposures is limited. Thus, we have developed a mice model for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. H. Yashavarddhan, Ajay Kumar Sharma, Pankaj Chaudhary, Sania Bajaj, Sukhvir Singh, Sandeep Kumar Shukla
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d0f3564a89ec42b6a0fd3abb5eb26578
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0f3564a89ec42b6a0fd3abb5eb26578
record_format dspace
spelling oai:doaj.org-article:d0f3564a89ec42b6a0fd3abb5eb265782021-12-02T15:12:52ZDevelopment of hematopoietic syndrome mice model for localized radiation exposure10.1038/s41598-020-80075-w2045-2322https://doaj.org/article/d0f3564a89ec42b6a0fd3abb5eb265782021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80075-whttps://doaj.org/toc/2045-2322Abstract Current models to study the hematopoietic syndrome largely rely on the uniform whole-body exposures. However, in the radio-nuclear accidents or terrorist events, exposure can be non-uniform. The data available on the non-uniform exposures is limited. Thus, we have developed a mice model for studying the hematopoietic syndrome in the non-uniform or partial body exposure scenarios using the localized cobalt60 gamma radiation exposure. Femur region of Strain ‘A’ male mice was exposed to doses ranging from 7 to 20 Gy. The 30 day survival assay showed 19 Gy as LD100 and 17 Gy as LD50. We measured an array of cytokines and important stem cell markers such as IFN-γ, IL-3, IL-6, GM-CSF, TNF-α, G-CSF, IL-1α, IL-1β, CD 34 and Sca 1. We found significant changes in IL-6, GM-CSF, TNF-α, G-CSF, and IL-1β levels compared to untreated groups and amplified levels of CD 34 and Sca 1 positive population in the irradiated mice compared to the untreated controls. Overall, we have developed a mouse model of the hematopoietic acute radiation syndrome that might be useful for understanding of the non-uniform body exposure scenarios. This may also be helpful in the screening of drugs intended for individuals suffering from radiation induced hematopoietic syndrome.M. H. YashavarddhanAjay Kumar SharmaPankaj ChaudharySania BajajSukhvir SinghSandeep Kumar ShuklaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
M. H. Yashavarddhan
Ajay Kumar Sharma
Pankaj Chaudhary
Sania Bajaj
Sukhvir Singh
Sandeep Kumar Shukla
Development of hematopoietic syndrome mice model for localized radiation exposure
description Abstract Current models to study the hematopoietic syndrome largely rely on the uniform whole-body exposures. However, in the radio-nuclear accidents or terrorist events, exposure can be non-uniform. The data available on the non-uniform exposures is limited. Thus, we have developed a mice model for studying the hematopoietic syndrome in the non-uniform or partial body exposure scenarios using the localized cobalt60 gamma radiation exposure. Femur region of Strain ‘A’ male mice was exposed to doses ranging from 7 to 20 Gy. The 30 day survival assay showed 19 Gy as LD100 and 17 Gy as LD50. We measured an array of cytokines and important stem cell markers such as IFN-γ, IL-3, IL-6, GM-CSF, TNF-α, G-CSF, IL-1α, IL-1β, CD 34 and Sca 1. We found significant changes in IL-6, GM-CSF, TNF-α, G-CSF, and IL-1β levels compared to untreated groups and amplified levels of CD 34 and Sca 1 positive population in the irradiated mice compared to the untreated controls. Overall, we have developed a mouse model of the hematopoietic acute radiation syndrome that might be useful for understanding of the non-uniform body exposure scenarios. This may also be helpful in the screening of drugs intended for individuals suffering from radiation induced hematopoietic syndrome.
format article
author M. H. Yashavarddhan
Ajay Kumar Sharma
Pankaj Chaudhary
Sania Bajaj
Sukhvir Singh
Sandeep Kumar Shukla
author_facet M. H. Yashavarddhan
Ajay Kumar Sharma
Pankaj Chaudhary
Sania Bajaj
Sukhvir Singh
Sandeep Kumar Shukla
author_sort M. H. Yashavarddhan
title Development of hematopoietic syndrome mice model for localized radiation exposure
title_short Development of hematopoietic syndrome mice model for localized radiation exposure
title_full Development of hematopoietic syndrome mice model for localized radiation exposure
title_fullStr Development of hematopoietic syndrome mice model for localized radiation exposure
title_full_unstemmed Development of hematopoietic syndrome mice model for localized radiation exposure
title_sort development of hematopoietic syndrome mice model for localized radiation exposure
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d0f3564a89ec42b6a0fd3abb5eb26578
work_keys_str_mv AT mhyashavarddhan developmentofhematopoieticsyndromemicemodelforlocalizedradiationexposure
AT ajaykumarsharma developmentofhematopoieticsyndromemicemodelforlocalizedradiationexposure
AT pankajchaudhary developmentofhematopoieticsyndromemicemodelforlocalizedradiationexposure
AT saniabajaj developmentofhematopoieticsyndromemicemodelforlocalizedradiationexposure
AT sukhvirsingh developmentofhematopoieticsyndromemicemodelforlocalizedradiationexposure
AT sandeepkumarshukla developmentofhematopoieticsyndromemicemodelforlocalizedradiationexposure
_version_ 1718387661539901440